
Background Hypertension frequently coexists with type 2 diabetes (T2D) and may contribute to the development of diabetic complications. Objective This study aimed to assess the association between hypertension and microvascular and macrovascular complications in patients with type 2 diabetes (T2D). Methods We conducted a retrospective cross-sectional study based on a review of medical records, including 500 patients with T2D followed in the Department of Endocrinology, Diabetology, and Nutrition. Patients were grouped according to the presence of hypertension, with 204 patients in the hypertension group and 296 patients in the non-hypertension group. Clinical, biological, and complication-related data were collected and analyzed using appropriate statistical methods. Results The mean age was 58.3 ± 12.8 years, and hypertension was present in 40.8% of cases. Poor glycemic control (glycated hemoglobin [HbA1c] >10%) was observed in 52.2%. Patients with hypertension had higher frequencies of several microvascular and macrovascular complications compared with patients without hypertension. Nephropathy was more frequent among patients with hypertension than among those without hypertension (32.8% vs. 14.2%; OR = 2.96, 95% CI: 1.91–4.58; p < 0.001). Higher grades of hypertension were significantly associated with peripheral arterial disease and cerebrovascular accident. Longer diabetes duration was associated with retinopathy, neuropathy, and cerebrovascular accident, whereas longer hypertension duration was significantly associated with peripheral arterial disease. Conclusions Hypertension is significantly associated with a higher prevalence of both microvascular and macrovascular complications in patients with T2D. These findings support the importance of early identification and integrated management of hypertension, glycemic control, and other cardiovascular risk factors to reduce the burden of diabetic complications.
Background: Obstructive sleep apnea (OSA) is associated with substantial cardiovascular morbidity through mechanisms involving intermittent hypoxia, sympathetic activation, oxidative stress, and progressive cardiac remodeling. The present study aimed to comprehensively evaluate clinical characteristics, echocardiographic abnormalities, autonomic function, and independent factors associated with OSA in a case-control population. Methods: This observational, case-control study included 108 adults recruited from a tertiary sleep laboratory, 54 patients with OSA and 54 controls selected using frequency matching for age and sex and considered at low risk for OSA based on STOP-Bang screening. Clinical characteristics, cardiovascular risk factors, transthoracic echocardiographic parameters, structural cardiac abnormalities, and 24-hour Holter-derived autonomic indices were compared between groups. Continuous variables were analyzed using the Mann-Whitney U test, categorical variables using Pearson's chi-square or Fisher's exact test, and univariable and multivariable binary logistic regression analyses were performed to identify variables independently associated with OSA. Results: Compared with controls, patients with OSA had significantly higher prevalences of obesity, smoking, hypertension, diabetes mellitus, and ischemic heart disease (IHD). Echocardiography demonstrated larger left atrial and right ventricular diameters, higher pulmonary artery systolic pressure (PASP), and increased frequencies of left ventricular hypertrophy (LVH), diastolic dysfunction, and moderate tricuspid regurgitation (TR). Among the Holter-derived autonomic parameters, the root mean square of successive differences between adjacent normal-to-normal intervals (RMSSD) was significantly lower in patients with OSA in the unadjusted comparison. In multivariable linear regression analyses, the association between OSA and RMSSD was attenuated and did not reach statistical significance, while OSA was not independently associated with the standard deviation of normal-to-normal intervals (SDNN). In univariable logistic regression analyses, obesity, smoking, hypertension, diabetes mellitus, ischemic heart disease, left ventricular hypertrophy, and diastolic dysfunction were significantly associated with OSA. After multivariable adjustment, obesity [adjusted odds ratio (OR) 10.86, 95% confidence intervals (CI) 2.99–39.47], smoking (adjusted OR 4.88, 95% CI 1.32–18.14), ischemic heart disease (adjusted OR 19.17, 95% CI 1.65–222.41), and left ventricular hypertrophy (adjusted OR 3.54, 95% CI 1.01–12.40) remained independently associated with OSA. Conclusions: OSA was associated with structural cardiovascular abnormalities and an unadjusted difference in the Holter-derived autonomic parameter RMSSD, whereas neither RMSSD nor SDNN showed a statistically significant independent association with OSA after multivariable adjustment. Obesity, smoking, ischemic heart disease, and left ventricular hypertrophy were independently associated with the presence of OSA, underscoring the close relationship between sleep-disordered breathing and cardiovascular disease. Comprehensive cardiovascular evaluation may improve risk stratification and support earlier identification of patients at increased cardiovascular risk.
Background and aim: Liver cancer remains the sixth most common malignancy and the third leading cause of cancer-related death worldwide, with hepatocellular carcinoma accounting for most cases. Long non-coding RNAs regulate hepatocarcinogenesis by modulating proliferation, epithelial–mesenchymal transition, and invasion. This study aimed to characterize the expression of three such transcripts (MALAT1, NEAT1, NKILA) and two protein-coding genes of the Hippo/EMT axis (YAP1, SNAI1) in a single-center Romanian cohort of hepatocellular carcinoma patients and to interpret the resulting pattern in relation to the existing literature. Methods: Tumoral and non-tumoral liver tissue samples were obtained from patients with non-metastatic hepatocellular carcinoma undergoing surgical resection. Total RNA was extracted using TRIzol, reverse-transcribed, and quantified by SYBR Green–based qRT-PCR on a QuantStudio 7 Flex platform. Relative expression was calculated by the ΔΔCt method, normalized to B2M and 18S rRNA, and compared between the two groups using GraphPad Prism; p < 0.05 was considered significant. Results: 39 tumoral and 39 non-tumoral tissue samples were analyzed. MALAT1 (p = 0.0008), YAP1 (p = 0.0016), and SNAI1 (p = 0.0365) were significantly overexpressed in tumoral tissue, whereas NEAT1 was significantly reduced (p = 0.0320). NKILA showed no significant difference between groups (p = 0.3592). Effect sizes were graded, with the strongest separation for MALAT1 and YAP1 and more modest differences for SNAI1 and NEAT1. Conclusion: MALAT1, YAP1, and SNAI1 overexpression in hepatocellular carcinoma was confirmed in a single-center cohort from Romania, including predominantly early-stage subjects. The reduction of NEAT1 diverges from most prior reports and may reflect isoform-specific detection or the molecular abnormality of the cirrhotic tissue comparator. Future work should incorporate isoform-specific assays, etiology-stratified cohorts, and outcome correlation.
Background: Benign soft tissue lesions of the oro-maxillofacial region feature diverse clinical presentations that often overlap, making histopathological validation essential. This study evaluated the demographic, anatomical, and clinicopathological characteristics of these lesions over 10 years, focusing on associations between diagnosis and anatomical site. Methods: This retrospective observational study analyzed 170 patients diagnosed between January 2014 and December 2023. Patient age, sex, lesion location, histopathological diagnosis, epithelial lining, histomorphological features, and inflammatory status were collected from medical and pathology records. Data were analyzed using descriptive statistics and Pearson's Chi-square or Fisher's exact tests via IBM SPSS v26.0 (α= 0.05). Results: The mean patient age was 49.3 years, predominantly impacting individuals over 40, with a slight female predominance (55.9%). The most frequent anatomical locations were the labial, buccal, parotid, and cervical regions. Nevus, fibroma, epidermoid cyst, mucocele, and lipoma were the primary diagnoses. Stratified squamous epithelium was the predominant lining, and inflammatory infiltrate was present in 48.2% of cases. A highly significant association was confirmed between histopathological diagnosis and anatomical location (p < 0.001). Conclusions: Benign oro-maxillofacial cysts and soft tissue lesions exhibit distinct clinicopathological and topographic patterns. Recognizing these site-specific associations enhances diagnostic accuracy and management planning, though further multicenter prospective verification is recommended.
Objective: This study aims to review studies on Janus kinase inhibitors (JAKi) in order to determine their efficacy and safety in the treatment of erosive oral lichen planus (OLP). Design and data sources: A systematic review was conducted through PubMed/Medline, Google Scholar, and ScienceDirect databases using PRISMA guidelines. Study quality assessment was performed using Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Case Reports and Case Series. Eligibility criteria: Case reports, and case series published between January 2020 - November 2025 with no language or geographic restrictions. Data extraction and synthesis: Retrieved data included patient demographics and disease outcomes. Descriptive statistical analyses and qualitative data synthesis were employed. Results: A total of 15 case reports / series described 45 patients. Patients were mostly females (94.7%), with an age range of 30-89 years (weighted mean=55.31 years). A total of seven JAKi have been described for the management of OLP, of which tofacitinib and upadacitinib were the most commonly prescribed. A total of 18 patients (40.0%) showed complete resolution with treatment durations extending from 3 months-6 years. Seventeen patients (37.7%) required adjunctive corticosteroids, or other immunosuppressive treatment. Reported adverse effects were mostly mild in the form of cutaneous, gastrointestinal and liver disturbances. Conclusions: To date, seven different JAKi have been reported to be effective in the treatment of erosive OLP. Current evidence suggests that JAKi may represent a promising and generally well-tolerated therapeutic option for erosive OLP patients, particularly those with refractory disease. Nevertheless, further research is warranted to establish their long-term efficacy and safety. Future studies should focus on optimizing treatment duration, evaluating the role of combination immunomodulatory therapies, and identifying patient-related factors that may influence treatment outcomes.